Posted on January 4, 2022
By Rebekah Martin | AstraZeneca, Senior Vice President of Reward and Inclusion
January 24, 2022
By Alexander M. Haydl | Boehringer Ingelheim Germany, Head of Late-Stage Development Laboratory and Product Owner of Digital Process Development
Personal and Career Development from then to nowI am a Boehringer Ingelheim associate. The herein described view expressed in this article is my own and not endorsed by Boehringer Ingelheim. Applying the principle of ‘Aikido’ by turning weaknesses into strengths led me from ‘downs’ I had within my recent career into even more uplifting ‘ups’ […]
November 17, 2021
By Bo Quan Tan | Lonza Singapore, Manager of Project Engineering Department
May 20, 2022
By Jason Rudd | Amgen, Statistical Programming Manager
January 28, 2022
By Stuart Flanagan | Evotec, Group Leader
February 23, 2022
By Jürgen Schrapp | Bayer, Head of R&D Procurement
December 7, 2022
By Ahmed Elhusseiny | Roche Pharmaceuticals, Area Head, Asia Pacific
March 7, 2022
By Vijetha Bhat | Lonza, Houston,Texas, Scientist, Research and Development
June 24, 2021
By Francis Van Parys | Cytiva, Vice President Commercial Asia Pacific
June 16, 2021
By Rajeev Nair | Merck, Senior Vice President & Head of Asia Pacific - Research Solutions
August 31, 2021
By Teresa Foy | Bristol Myers Squibb, Sr Vice President Immuno-Oncology and Cellular Therapy
December 21, 2021
By Kaja Natland | Organon, Regional President, Asia Pacific & Japan
March 10, 2022
By Elizabeth Jurica | Bristol Myers Squibb, Principal Scientist
January 11, 2022
By Jennifer Snyder | Novartis Pharmaceuticals, Director, Portfolio Strategy Management for Technical Research and Development Cell & Gene Therapy
